3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Neoplasms
19
Breast Neoplasms
18
Leukemia, Myeloid, Acute
9
Ovarian Neoplasms
6
Lymphoma
6
Hematologic Neoplasms
6
Glioblastoma
6
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Neoplasm Metastasis
5
Multiple Myeloma
5
Lung Neoplasms
5
Stomach Neoplasms
4
Leukemia
4
Fatigue
4
Vulvar Neoplasms
3
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Myelodysplastic Syndromes
3
Motor Activity
3
Depression
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Anxiety Disorders
3
Vaginal Neoplasms
2
Sarcoma
2
Rectal Neoplasms
2
Peritoneal Neoplasms
2
Pain
2
Interventions
Metformin
7
Surveys and Questionnaires
3
Nutrition Assessment
3
Exercise
3
Tirzepatide
2
Therapeutics
2
Tablets
2
Standard of Care
2
Specimen Handling
2
Resistance Training
2
Methods
2
Interviews as Topic
2
Glucose Tolerance Test
2
Educational Status
2
Biopsy
2
tocilizumab
1
tislelizumab
1
pembrolizumab
1
epalrestat
1
donafenib
1
amlodipine, atorvastatin drug combination
1
Verapamil
1
Urine Specimen Collection
1
Testosterone
1
Secretin
1
Second Harmonic Generation Microscopy
1
Risk Assessment
1
Remote Consultation
1
Preventive Health Services
1
Practice Guidelines as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Diabetes Mellitus
×
Palliative Care
×
Clear all
NCT04836221
2023-06-18
CARES
Medstar Health Research Institute
Phase NA
Completed
63 enrolled